This one-hour, on-demand, journal article-based activity explores examines the relationship between higher first 30-day buprenorphine doses and a reduction in opioid-involved overdose death and death from all other causes. It provides evidence supporting the benefits of higher dosing in reducing mortality and may be used to inform existing clinical practice norms for MOUD treatment in order to enhance patient safety and reduce patient mortality.
- Provider:American Society of Addiction Medicine
- Activity Link: https://www.elearning.asam.org/p/JAM24_101097ADM0000000000001300
- Start Date: 2024-06-04 05:00:00
- End Date: 2024-06-04 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours
Social Work: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: No
- Activity Type: Journal-based CE
- CME Finder Type: Other
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Critical Care Medicine, General Pediatrics, Hospital Medicine, Internal Medicine, Medical Toxicology, Pediatric Critical Care Medicine
Subscribe
Login
0 Comments
Oldest